6-32845659-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_000593.6(TAP1):c.2167G>T(p.Gly723Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000342 in 1,460,768 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000593.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TAP1 | NM_000593.6 | c.2167G>T | p.Gly723Trp | missense_variant | 11/11 | ENST00000354258.5 | NP_000584.3 | |
PSMB8-AS1 | NR_037173.1 | n.657C>A | non_coding_transcript_exon_variant | 3/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TAP1 | ENST00000354258.5 | c.2167G>T | p.Gly723Trp | missense_variant | 11/11 | 1 | NM_000593.6 | ENSP00000346206 | P1 | |
PSMB8-AS1 | ENST00000453426.2 | n.431C>A | non_coding_transcript_exon_variant | 2/2 | 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000162 AC: 4AN: 246538Hom.: 0 AF XY: 0.00000744 AC XY: 1AN XY: 134396
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1460768Hom.: 0 Cov.: 31 AF XY: 0.00000413 AC XY: 3AN XY: 726698
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
MHC class I deficiency Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 19, 2019 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals with TAP1-related conditions. This variant is present in population databases (rs768348425, ExAC 0.009%). This sequence change replaces glycine with tryptophan at codon 783 of the TAP1 protein (p.Gly783Trp). The glycine residue is weakly conserved and there is a large physicochemical difference between glycine and tryptophan. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 19, 2022 | The c.2347G>T (p.G783W) alteration is located in exon 11 (coding exon 11) of the TAP1 gene. This alteration results from a G to T substitution at nucleotide position 2347, causing the glycine (G) at amino acid position 783 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at